19-17101752-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004145.4(MYO9B):c.35G>A(p.Arg12Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000653 in 1,593,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004145.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO9B | NM_004145.4 | c.35G>A | p.Arg12Gln | missense_variant | 2/40 | ENST00000682292.1 | NP_004136.2 | |
MYO9B | NM_001130065.2 | c.35G>A | p.Arg12Gln | missense_variant | 2/40 | NP_001123537.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO9B | ENST00000682292.1 | c.35G>A | p.Arg12Gln | missense_variant | 2/40 | NM_004145.4 | ENSP00000507803.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000592 AC: 13AN: 219460Hom.: 0 AF XY: 0.0000663 AC XY: 8AN XY: 120618
GnomAD4 exome AF: 0.0000645 AC: 93AN: 1441090Hom.: 0 Cov.: 31 AF XY: 0.0000656 AC XY: 47AN XY: 716358
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74424
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | The c.35G>A (p.R12Q) alteration is located in exon 2 (coding exon 1) of the MYO9B gene. This alteration results from a G to A substitution at nucleotide position 35, causing the arginine (R) at amino acid position 12 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at